Lee Han Ah
Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
J Liver Cancer. 2025 Mar;25(1):52-66. doi: 10.17998/jlc.2025.02.28. Epub 2025 Mar 20.
Hepatocellular carcinoma (HCC) presents unique challenges in both the elderly and adolescent/young adult (AYA) populations, requiring distinct management approaches. Recent epidemiological data show an increasing incidence of HCC in both age groups, with elderly cases rising significantly and AYA cases showing trends in specific regions. The clinical characteristics and treatment considerations vary substantially among these populations. Elderly patients with HCC typically present with hepatitis C virus infection, metabolic dysfunction-associated steatotic liver disease, well-differentiated tumors, and multiple comorbidities. In contrast, AYA patients with HCC often present with more aggressive tumor characteristics and predominantly with hepatitis B virus-related diseases. Treatment decisions for elderly patients with HCC require careful consideration of physiological reserves, comprehensive geriatric assessments, and potential complications. Recent studies have demonstrated that elderly patients can achieve outcomes comparable to younger patients across various treatment modalities when properly selected. While surgical outcomes are comparable to those of younger patients with proper selection, less-invasive options such as radiofrequency ablation or transarterial therapies may be more appropriate for some elderly patients. The treatment approach for AYA HCC emphasizes curative intent while considering long-term effects. AYA patients require specialized attention to their psychosocial needs, fertility preservation, and long-term health maintenance. Although data on AYA patients remain limited, they are known to have relatively favorable prognoses despite exhibiting more aggressive tumor characteristics. Management of HCC in both the elderly and AYA populations requires individualized approaches that consider age-specific factors. Both groups benefit from multidisciplinary team involvement and careful consideration of quality of life.
肝细胞癌(HCC)在老年人群和青少年/青年成人(AYA)人群中都带来了独特的挑战,需要不同的管理方法。最近的流行病学数据显示,这两个年龄组的HCC发病率都在上升,老年病例显著增加,AYA病例在特定地区呈现上升趋势。这些人群的临床特征和治疗考量差异很大。老年HCC患者通常伴有丙型肝炎病毒感染、代谢功能障碍相关脂肪性肝病、高分化肿瘤以及多种合并症。相比之下,AYA HCC患者往往具有更具侵袭性的肿瘤特征,且主要与乙型肝炎病毒相关疾病有关。老年HCC患者的治疗决策需要仔细考虑生理储备、全面的老年评估以及潜在并发症。最近的研究表明,经过适当选择,老年患者在各种治疗方式下都能取得与年轻患者相当的治疗效果。虽然手术效果在适当选择的情况下与年轻患者相当,但对于一些老年患者来说,诸如射频消融或经动脉治疗等侵入性较小的选择可能更为合适。AYA HCC的治疗方法在考虑长期影响的同时强调治愈意图。AYA患者需要特别关注他们的心理社会需求、生育力保护和长期健康维护。尽管关于AYA患者的数据仍然有限,但已知他们尽管肿瘤特征更具侵袭性,但预后相对较好。老年和AYA人群中HCC的管理都需要考虑年龄特异性因素的个体化方法。这两个群体都受益于多学科团队的参与以及对生活质量的仔细考量。